Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN103012175A details water-soluble curcumin salts. Enhances stability and bioavailability for pharmaceutical manufacturing.
Discover the full liquid-phase synthesis method for Gonadorelin outlined in patent CN113603752A, offering superior purity over 95% and significant cost reductions for pharmaceutical supply chains.
Novel bromination method reduces costs and improves safety for sartan drug intermediates with high atom economy and scalable production capabilities.
Patent CN109970516A details high-purity cannabinoid synthesis. Delivers cost reduction and supply reliability for pharmaceutical intermediates manufacturing.
Patent CN111944855B details a high-yield enzymatic route for (R)-1-(4-(benzyloxy)-3-nitrophenyl)-2-bromoethanol, offering superior stereoselectivity.
Patent CN101899044B reveals a greener route for Gemifloxacin main ring synthesis, eliminating hazardous reagents like NaH and ensuring reliable supply chain continuity.
Patent CN102976924B reveals asymmetric synthesis for high-purity intermediates. Enables cost reduction and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN110105368B reveals novel deoxy taxane synthesis improving solubility and anticancer activity, offering cost-effective API intermediate manufacturing strategies.
Novel synthesis route for high-purity antitumor intermediates reducing waste and cost for pharmaceutical manufacturing supply chains globally.
Patent CN111471003B details a cost-effective Negishi coupling route for sitagliptin intermediates, offering high purity and scalable manufacturing solutions.
Patent CN101157655A details a novel cinchona alkaloid-catalyzed route for (4S,5R)-half esters, offering superior yield and enantioselectivity for scalable biotin production.
Patent CN116348474B discloses efficient oxazoline sugar synthesis enabling specific peptide modification and complex molecule assembly for pharmaceutical research.
Patent CN106045891A reveals efficient one-pot synthesis for Vildagliptin intermediates offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN1291609A reveals a robust solid-base process for 5-lipoxygenase inhibitors. Achieve high purity and cost reduction in API manufacturing with scalable methods.
Novel chemical synthesis route for Saxagliptin intermediate eliminates enzymatic steps. Offers high yield and scalable production for reliable pharmaceutical intermediate supply chains.
Novel synthesis of 5,6-hydroxyl substituted brazilin analog via Prins/Friedel-Crafts reaction. Offers cost-effective route for bladder cancer drug intermediates.
Patent CN102180793B details a high-yield synthesis route for Vitamin E intermediates offering cost reduction and supply chain reliability for global buyers.
Patent CN102267917B reveals a greener synthesis route for methoxyphenamine hydrochloride, offering cost reduction in API manufacturing and superior supply chain reliability.
Novel synthesis of CAS 503105-88-2 via mild conditions. Cost-effective manufacturing for antibacterial intermediates.
Novel Grignard-based synthesis patent CN105820184A enables cost-effective manufacturing of high-purity 4-phenoxyphenylboronic acid for scalable pharmaceutical intermediate supply chains.